Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04314401 · ClinicalTrials.gov registry record

National Cancer Institute "Cancer Moonshot Biobank"

A clinical trial of Acute Myeloid Leukemia and Anatomic Stage III Breast Cancer AJCC v8, sponsored by National Cancer Institute (NCI).

Recruiting
Registry status
1,600
Enrollment target
20
Study locations

NCT04314401 is a study of Acute Myeloid Leukemia and Anatomic Stage III Breast Cancer AJCC v8 that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 1,600 participants, above the 111-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1341% higher). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04314401, a study of Acute Myeloid Leukemia and Anatomic Stage III Breast Cancer AJCC v8, is actively recruiting participants, sponsored by National Cancer Institute (NCI).

RECRUITING
Registry status
1,600 participants
Enrollment target
20
Study locations

Study Summary

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Conditions Studied

Acute Myeloid Leukemia Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Hormone Receptor-Positive Breast Carcinoma Clinical Stage IV Gastric Cancer AJCC v8 Esophageal Carcinoma Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Fallopian Tube Carcinoma Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 Gastric Carcinoma

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Computed Tomography
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Medical Chart Review
  • PROCEDURE Paracentesis

Study Locations (20)

Colorado

  • Intermountain Health Platte Valley Hospital - Brighton
  • Saint Joseph Hospital - Cancer Centers of Colorado - Denver
  • Lutheran Hospital - Cancer Centers of Colorado - Golden
  • Saint Mary's Hospital and Regional Medical Center - Grand Junction
  • Good Samaritan Hospital - Cancer Centers of Colorado - Lafayette

Alabama

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis - Daphne
  • Thomas Hospital - Fairhope
  • Mobile Infirmary Medical Center - Mobile
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland - Saraland

California

  • PCR Oncology - Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital - Bakersfield
  • Veterans Affairs Loma Linda Healthcare System - Loma Linda
  • Salinas Valley Memorial - Salinas

Delaware

  • Bayhealth Hospital Kent Campus - Dover
  • Bayhealth Hospital Sussex Campus - Milford

Florida

  • Boca Raton Regional Hospital - Boca Raton
  • Broward Health North - Deerfield Beach

Arizona

  • Kingman Regional Medical Center - Kingman

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith

Connecticut

  • Hartford Hospital - Hartford

Trial Details

FieldValue
Enrollment Target 1,600 participants
Start Date 2020-11-11
Est. Completion 2027-04-30

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04314401

The ClinicalTrials.gov registry entry for NCT04314401 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 111-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (1341% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT04314401 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Colorado, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT04314401 about?

NCT04314401 is a clinical study titled "National Cancer Institute "Cancer Moonshot Biobank"". This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking a...

What is the current status of trial NCT04314401?

This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 2020-11-11. Estimated completion is 2027-04-30.

What conditions does trial NCT04314401 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Clinical Stage IV Gastric Cancer AJCC v8.

What interventions are being tested in trial NCT04314401?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Computed Tomography (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Medical Chart Review (OTHER), Paracentesis (PROCEDURE).

Who is sponsoring clinical trial NCT04314401?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04314401 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Myeloid Leukemia

All registered trials for this condition

Anatomic Stage III Breast Cancer AJCC v8

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.